之江生物(688317)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688317 之江生物

已收盘 07-14 15:00:00

{"stockData":{"symbol":"688317","market":"SH","secType":"STK","nameCN":"之江生物","latestPrice":23.22,"timestamp":1752476400000,"preClose":19.35,"halted":0,"volume":19451268,"delay":0,"changeRate":0.2,"floatShares":192000000,"shares":192000000,"eps":-0.8867,"marketStatus":"已收盘","change":3.87,"latestTime":"07-14 15:00:00","open":19.42,"high":23.22,"low":19.42,"amount":427000000,"amplitude":0.1964,"askPrice":0,"askSize":0,"bidPrice":23.22,"bidSize":18799,"shortable":0,"etf":0,"ttmEps":-0.8867,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752543000000},"marketStatusCode":5,"adr":0,"adjPreClose":19.35,"symbolType":"stock_kcb","openAndCloseTimeList":[[1752456600000,1752463800000],[1752469200000,1752476400000]],"highLimit":21.29,"lowLimit":17.42,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":192157999,"isCdr":false,"pbRate":1.26,"roa":"--","roe":"--","epsLYR":-0.67,"committee":0,"marketValue":4462000000,"turnoverRate":0.1012,"status":0,"afterMarket":{"amount":0,"volume":0,"close":23.22,"buyVolume":60951,"sellVolume":0,"time":1752478438025,"indexStatus":"已收盘 07-14 15:30:00","preClose":19.35},"floatMarketCap":4462000000},"requestUrl":"/m/hq/s/688317","defaultTab":"news","newsList":[{"id":"2551901399","title":"7月14日之江生物（688317）龙虎榜数据：机构净卖出1263.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551901399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551901399?lang=zh_cn&edition=full","pubTime":"2025-07-14 17:16","pubTimestamp":1752484595,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年7月14日公布的交易公开信息显示，之江生物因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月14日收盘，之江生物报收于23.22元，上涨20.0%，涨停，换手率10.12%，成交量19.45万手，成交额4.27亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出1263.32万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400024646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"gpt_icon":0},{"id":"2551904166","title":"肝炎概念盘中拉升，之江生物涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2551904166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551904166?lang=zh_cn&edition=full","pubTime":"2025-07-14 14:32","pubTimestamp":1752474770,"startTime":"0","endTime":"0","summary":"07月14日，肝炎概念盘中拉升，截至14点32分，肝炎概念整体指数上涨1.00%，报1043.310点。从个股上来看，该概念的成分股中，之江生物涨停，一品红涨幅超过5%。从资金上来看，截止发稿，肝炎概念概念主力净流入为-2.66亿，其中之江生物受到资金热捧，主力净流入1.04亿；拉长时间线来看，该板块近20日主力资金净流入-74.90亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714143250a4491fbb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714143250a4491fbb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688317"],"gpt_icon":0},{"id":"2551738309","title":"异动快报：之江生物（688317）7月14日11点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2551738309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551738309?lang=zh_cn&edition=full","pubTime":"2025-07-14 11:15","pubTimestamp":1752462918,"startTime":"0","endTime":"0","summary":"证券之星7月14日盘中消息，11点14分之江生物触及涨停板。目前价格23.15，上涨19.64%。其所属行业医疗器械目前上涨。领涨股为易瑞生物。该股为猴痘概念，体外诊断，新冠病毒防治概念热股，当日猴痘概念概念上涨1.09%，体外诊断概念上涨0.46%，新冠病毒防治概念上涨0.38%。7月11日的资金流向数据方面，主力资金净流出975.79万元，占总成交额12.28%，游资资金净流入150.95万元，占总成交额1.9%，散户资金净流入824.84万元，占总成交额10.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400009978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688317"],"gpt_icon":0},{"id":"2551297980","title":"新冠抗原检测概念盘中拉升，易瑞生物等2只股票涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2551297980","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551297980?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:54","pubTimestamp":1752461690,"startTime":"0","endTime":"0","summary":"07月14日，新冠抗原检测概念盘中拉升，截至10点54分，新冠抗原检测概念整体指数上涨1.04%，报978.650点。从个股上来看，该概念的成分股中，长荣股份涨幅超过10%，易瑞生物等2只股票涨停，之江生物涨幅超过5%。从资金上来看，截止发稿，新冠抗原检测概念主力净流入为-4095.54万，其中长荣股份受到资金热捧，主力净流入1.10亿；拉长时间线来看，该板块近20日主力资金净流入-53.00亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410545097a5165c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410545097a5165c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300942","BK0239","688317"],"gpt_icon":0},{"id":"2549478613","title":"每周股票复盘：之江生物（688317）账上现金充裕达26.4亿元规划明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2549478613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549478613?lang=zh_cn&edition=full","pubTime":"2025-07-06 04:13","pubTimestamp":1751746387,"startTime":"0","endTime":"0","summary":"截至2025年7月4日收盘，之江生物报收于18.72元，较上周的17.71元上涨5.7%。本周，之江生物7月4日盘中最高价报19.23元。6月30日盘中最低价报17.63元。之江生物当前最新总市值35.97亿元，在医疗器械板块市值排名93/126，在两市A股市值排名3869/5149。2025年一季度，公司利息收入约为1138万元。公司已累计完成3次股份回购，目前正在进行2025年的第2次回购。截至2025年6月25日，共回购股份约1533万股，购专户持有约1278万股，占总股本的6.66%，其中，250多万股已完成注销。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600000508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688317","BK0239"],"gpt_icon":0},{"id":"2548359590","title":"之江生物股价上涨5.17%创近6个月新高 资金博弈加剧估值分歧及转型期不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2548359590","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548359590?lang=zh_cn&edition=full","pubTime":"2025-07-04 13:08","pubTimestamp":1751605692,"startTime":"0","endTime":"0","summary":"之江生物股价今日表现强势，截至13点07分，公司股价上涨5.17%，报18.91元/股，盘中创出近6个月以来新高。资金博弈加剧估值分歧近期之江生物股价波动受多重短期因素扰动。公司动态市盈率-56.75倍，市净率1.03倍仍低于行业均值，转型期估值分歧进一步放大股价弹性。业绩拐点决定估值重构空间长期来看，之江生物业务结构调整仍是核心变量。但需注意，公司2024年前三季度净利润仍为负值，动态市盈率持续为负反映盈利能力的实质性改善仍需时间验证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704130822a4ceb5b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704130822a4ceb5b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688317","BK0239"],"gpt_icon":0},{"id":"2548075405","title":"之江生物：累计回购2.14%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2548075405","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548075405?lang=zh_cn&edition=full","pubTime":"2025-07-01 15:53","pubTimestamp":1751356403,"startTime":"0","endTime":"0","summary":"格隆汇7月1日丨之江生物(688317.SH)公布，截至2025年6月30日，公司通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份4,116,673股，占公司当前总股本的比例为2.14%，回购成交的最高价为18.02元/股，最低价为16.50元/股，支付的资金总额为人民币71,948,955.53元（不含印花税、交易佣金等交易费用）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070115533897959bc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070115533897959bc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688317","BK0239"],"gpt_icon":0},{"id":"2547015164","title":"中国创新药能否持续让世界买单？券商分析师最新观点","url":"https://stock-news.laohu8.com/highlight/detail?id=2547015164","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547015164?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:29","pubTimestamp":1751297340,"startTime":"0","endTime":"0","summary":"医药魔方统计，2025年1—5月，中国创新药企对外授权交易总金额已达455亿美元，超过2024年上半年的交易总额，创新药出海授权交易大爆发。亮眼数据的背后，是中国创新药整体水平的强势崛起。“中国创新药产业的研发、临床与生产能力，正处于与国际一线水平接轨的初始阶段。”由于BD数据不及预期，年内大涨明显的创新药企业荣昌生物股价近期大幅回调，从而带动创新药板块整体调整。华泰柏瑞恒生创新药ETF6月中旬以来一度单周下行超过8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630233154a7267585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600380","603087","688073","603707","600216","688222","600535","688506","688181","600079","600998","600056","600521","603259","603367","688488","688235","BK0239","603229","688278","600420","601089","600062","600851","600881","600351","159992","600645","688513","600222","688520","600267","688331","600200","688117","688198","06160","688091","688321","600422","600332","600867","688131","688163","600572","688166","600557","600682","603716","688356","688177","688189","600276","603567","688136","688317","688202","601607","600774","688319","600080","603590","688505","600789","688336","600196","600513","605199","688068","ONC","603127","603998","603456","600721"],"gpt_icon":0},{"id":"2547960709","title":"每周股票复盘：之江生物（688317）回购股份比例达2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547960709","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547960709?lang=zh_cn&edition=full","pubTime":"2025-06-29 04:39","pubTimestamp":1751143149,"startTime":"0","endTime":"0","summary":"截至2025年6月27日收盘，之江生物报收于17.71元，较上周的17.41元上涨1.72%。本周，之江生物6月26日盘中最高价报17.94元。之江生物当前最新总市值34.03亿元，在医疗器械板块市值排名93/126，在两市A股市值排名3987/5151。本周关注点之江生物：累计已回购股数占总股本比例2.07%公司公告汇总之江生物于2025年进行了第二次以集中竞价交易方式回购公司股份的行动，回购比例达到了总股本的2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062900000864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688317","BK0239"],"gpt_icon":0},{"id":"2546044092","title":"之江生物已回购398万股 总额6947万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546044092","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546044092?lang=zh_cn&edition=full","pubTime":"2025-06-26 16:08","pubTimestamp":1750925332,"startTime":"0","endTime":"0","summary":"6月26日，之江生物（688317）发布公告，截至2025年6月25日，公司已回购398万股，占总股本的2.07%，回购资金总额为6947万元，回购价格区间为16.5元/股至18.02元/股。2025年一季度，之江生物实现收入3213万元，归母净利润-1602万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626161004978f9e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626161004978f9e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688317","BK0239"],"gpt_icon":0},{"id":"2546183772","title":"之江生物06月25日主力净流入45.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2546183772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546183772?lang=zh_cn&edition=full","pubTime":"2025-06-25 15:20","pubTimestamp":1750836056,"startTime":"0","endTime":"0","summary":"06月25日, 之江生物股价涨0.40%，报收17.78元，成交金额1895.1万元，换手率0.56%，振幅0.96%，量比1.12。之江生物今日主力资金净流入45.4万元，上一交易日主力净流出129.0万元。该股近5个交易日上涨1.20%，主力资金累计净流入191.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出235.7万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625171204a71cbe1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625171204a71cbe1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688317"],"gpt_icon":0},{"id":"2544147023","title":"之江生物06月20日获主力加仓186.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544147023","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544147023?lang=zh_cn&edition=full","pubTime":"2025-06-20 15:21","pubTimestamp":1750404069,"startTime":"0","endTime":"0","summary":"06月20日，之江生物股价收平报17.41元，成交金额1015.2万元，换手率0.30%，振幅1.15%，量比0.43。之江生物今日主力资金净流入186.2万元，上一交易日主力净流入97.3万元。|06月20日主力加仓幅度排名||#|股票简称|主力净额占比|#|N华之杰|25.53%|#|N新恒汇|25.40%|#|川润股份|8.72%|#|...|...|#944|之江生物|0.06%|之江生物所在的医疗器械行业，今日主力净流出1.84亿元，行业排名49/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620170855a4b4465a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620170855a4b4465a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688317","BK0239"],"gpt_icon":0},{"id":"2544153902","title":"之江生物：公司正在积极推进境外投资备案/核准程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2544153902","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544153902?lang=zh_cn&edition=full","pubTime":"2025-06-19 15:34","pubTimestamp":1750318447,"startTime":"0","endTime":"0","summary":"证券之星消息，之江生物(688317)06月19日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司在日本开展投资项目进展如何？之江生物回复：您好！感谢您对公司海外业务的关注。公司正在积极推进境外投资备案/核准程序，审批通过后将按计划有序推进项目建设。再次感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061900016949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688317","BK0239"],"gpt_icon":0},{"id":"2544137110","title":"精准医疗概念盘中跳水，之江生物跌1.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544137110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544137110?lang=zh_cn&edition=full","pubTime":"2025-06-19 14:18","pubTimestamp":1750313920,"startTime":"0","endTime":"0","summary":"06月19日，精准医疗概念盘中跳水，截至14点18分，精准医疗概念整体指数下跌2.02%，报945.280点。从个股上来看，该概念的成分股中，之江生物跌1.20%，诚迈科技、恩华药业、复星医药跌幅居前。从资金上来看，截止发稿，精准医疗概念主力净流入为-4.86亿，其中千红制药受到资金热捧，主力净流入3236.90万；拉长时间线来看，该板块近20日主力资金净流入-43.91亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619141840a4b1fb88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619141840a4b1fb88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688317"],"gpt_icon":0},{"id":"2544922103","title":"之江生物06月18日遭主力抛售44.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544922103","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544922103?lang=zh_cn&edition=full","pubTime":"2025-06-18 15:20","pubTimestamp":1750231244,"startTime":"0","endTime":"0","summary":"06月18日, 之江生物股价跌0.73%，报收17.57元，成交金额1975.4万元，换手率0.58%，振幅1.64%，量比0.86。之江生物今日主力资金净流出44.1万元，连续4日净流出，上一交易日主力净流出218.1万元。该股近5个交易日下跌1.95%，主力资金累计净流出433.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出956.7万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618165546a7102244&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618165546a7102244&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688317"],"gpt_icon":0},{"id":"2544794544","title":"新冠药物概念盘中跳水，ST百灵跌0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544794544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544794544?lang=zh_cn&edition=full","pubTime":"2025-06-18 10:53","pubTimestamp":1750215201,"startTime":"0","endTime":"0","summary":"06月18日，新冠药物概念盘中跳水，截至10点53分，新冠药物概念整体指数下跌2.01%，报649.970点。从个股上来看，该概念的成分股中，ST百灵跌0.95%，前沿生物-U、之江生物、科伦药业跌幅居前。从资金上来看，截止发稿，新冠药物概念主力净流入为-6.31亿，其中海辰药业受到资金热捧，主力净流入3935.18万；拉长时间线来看，该板块近20日主力资金净流入-69.04亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061810532197844fb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061810532197844fb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0146","688317","688221","BK0239","002424","BK0183","BK0028","BK0077","BK0188"],"gpt_icon":0},{"id":"2544501809","title":"之江生物06月17日遭主力抛售218.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544501809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544501809?lang=zh_cn&edition=full","pubTime":"2025-06-17 15:20","pubTimestamp":1750144817,"startTime":"0","endTime":"0","summary":"06月17日, 之江生物股价跌0.56%，报收17.70元，成交金额2388.6万元，换手率0.70%，振幅2.75%，量比0.91。之江生物今日主力资金净流出218.1万元，连续3日净流出，上一交易日主力净流出59.6万元。|06月17日主力加仓幅度排名||#|股票简称|主力净额占比|#|胜通能源|8.61%|#|爱朋医疗|6.73%|#|融发核电|4.93%|#|...|...|#3333|之江生物|-0.06%|之江生物所在的医疗器械行业，今日主力净流入3.65亿元，行业排名6/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617170118a4aded93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617170118a4aded93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688317","BK0239"],"gpt_icon":0},{"id":"2543622181","title":"最火赛道再迎重磅利好，创新药行情还能持续多久？","url":"https://stock-news.laohu8.com/highlight/detail?id=2543622181","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543622181?lang=zh_cn&edition=full","pubTime":"2025-06-16 16:33","pubTimestamp":1750062792,"startTime":"0","endTime":"0","summary":"当下最火赛道——创新药再迎重磅利好！其中提到，为进一步支持以临床价值为导向的创新药研发，提高临床研发质效，对符合要求的创新药临床试验申请在30个工作日内完成审评审批。近期，医药股利好持续发酵。另外6月13日，石药集团宣布与阿斯利康达成合作协议，将利用AI技术平台发现和开发新型口服小分子创新药。今日尾盘，创新药依然出现了结构性大涨。那么，创新药的行情还能持续多久？展望2025，医药围绕创新药要持续乐观。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616164703a4aba967&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616164703a4aba967&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688336","603367","688131","BK0201","600521","600851","688550","688222","688658","BK0070","688319","688317","BK0239","688091","688202","BK0185","688710","BK0028","600200","159992","688505","603127","BK0012","688136","BK0188","688189","600645","688117","600513","600721"],"gpt_icon":0},{"id":"2543284502","title":"之江生物06月13日主力净流出197.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2543284502","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543284502?lang=zh_cn&edition=full","pubTime":"2025-06-13 15:21","pubTimestamp":1749799291,"startTime":"0","endTime":"0","summary":"06月13日, 之江生物股价跌2.16%，报收17.66元，成交金额2861.3万元，换手率0.84%，振幅2.60%，量比1.05。之江生物今日主力资金净流出197.8万元，上一交易日主力净流入85.8万元。该股近5个交易日下跌0.84%，主力资金累计净流入196.3万元；近20日主力资金累计净流出22.2万元，其中净流出天数为8日。|06月13日主力加仓幅度排名||#|股票简称|主力净额占比|#|北方长龙|9.12%|#|通源石油|8.22%|#|海能达|5.30%|#|...|...|#2503|之江生物|-0.06%|之江生物所在的医疗器械行业，今日主力净流出3.95亿元，行业排名49/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613170952a4a709e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613170952a4a709e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688317"],"gpt_icon":0},{"id":"2542303398","title":"之江生物：累计回购1.03%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2542303398","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542303398?lang=zh_cn&edition=full","pubTime":"2025-06-11 15:37","pubTimestamp":1749627437,"startTime":"0","endTime":"0","summary":"格隆汇6月11日丨之江生物(688317.SH)公布，截至2025年6月10日，公司通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份1,982,232股，占公司当前总股本192,157,999股的比例为1.03%，与上次披露数相比增加0.32%，回购成交的最高价为18.02元/股，最低价为16.50元/股，支付的资金总额为人民币34,274,310.09元（不含印花税、交易佣金等交易费用）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611153952977a93e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611153952977a93e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688317","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752505675561,"stockEarnings":[{"period":"1week","weight":0.0337},{"period":"1month","weight":0.0798},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.2333},{"period":"1year","weight":0.3314},{"period":"ytd","weight":0.1908}],"compareEarnings":[{"period":"1week","weight":0.0109},{"period":"1month","weight":0.0317},{"period":"3month","weight":0.084},{"period":"6month","weight":0.1078},{"period":"1year","weight":0.1817},{"period":"ytd","weight":0.0473}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海之江生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"15832人(较上一季度减少3.90%)","perCapita":"12137股","listingDate":"2021-01-18","address":"上海市浦东新区张江高科技产业东区瑞庆路528号20幢乙号1层、21幢甲号1层","registeredCapital":"19215万元","survey":"　　上海之江生物科技股份有限公司的主营业务是分子诊断试剂及仪器设备的研发、生产和销售。公司的主要产品是分子诊断试剂和仪器设备。报告期内，公司相继获得权威机构的认可和荣誉，在2024年第三届金筛奖评选中获得ZAODX世界肿瘤早筛大会组织委员会授予的企业社会责任奖，“小青耕-AutraMic mini4800 Plus全自动分子检测一体机”荣获上海长三角医疗器械产业发展促进会“2024年度长三角优秀国产医疗设备耗材遴选”医疗设备类推荐产品。","listedPrice":43.22},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"之江生物(688317)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供之江生物(688317)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"之江生物,688317,之江生物股票,之江生物股票老虎,之江生物股票老虎国际,之江生物行情,之江生物股票行情,之江生物股价,之江生物股市,之江生物股票价格,之江生物股票交易,之江生物股票购买,之江生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"之江生物(688317)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供之江生物(688317)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}